United Bank »

Lineage Cell Therapeutics In shares owned by United Bank

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by United Bank from 13F filings

Historical chart of United Bank investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by United Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by United Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 30k 1.09
2023-09-30 $35k 30k 1.18
2023-06-30 $36k 26k 1.41

More positions owned by United Bank

Hubbell Common Stock (HUBB)
Apple Common Stock (AAPL)
Ishares Common Stock (IJR)
Microsoft Common Stock (MSFT)
Msci Em Ex China Index Common Stock (EMXC)
United Bankshares Common Stock (UBSI)
Ishares Etf-fixed Incom (IGSB)
Iron Mountain Common Stock (IRM)
Chevron Corporation Common Stock (CVX)
Mcdonalds Corp Common Stock (MCD)
Amgen Common Stock (AMGN)
Jpmorgan Chase & Co Common Stock (JPM)
Waste Management Common Stock (WM)
Procter & Gamble Common Stock (PG)
Abbott Laboratories Common Stock (ABT)

View all positions for United Bank

Top funds holding Lineage Cell Therapeutics In

Vanguard Group
Defender Capital
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Barclays
Royal Bank of Canada
Squarepoint Ops
Jane Street

View all funds holding Lineage Cell Therapeutics In